.Nature Medication, Published online: 16 September 2024 doi:10.1038/ s41591-024-03244-8In the empirical SCRUM-Japan GOZILA study, after a typical consequence of 11 months, clients along with metastatic intestinal growths who got biomarker-matched treatments based upon flowing lump DNA profiling showed a better scientific benefit than those obtaining incomparable treatment.